Stroke - A medical emergency

Journal of Accident and Emergency Medicine

Volumn 16, Issue 1, 1999, Pages 2-7

  Lott, C ^a   Hennes, Hans J ^a   Dick, W ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Acute ischaemic stroke; Emergency medical services; Stroke team; Thrombolysis

Indexed keywords

ALTEPLASE; ANTITHROMBOCYTIC AGENT; APTINAGEL; ELIPRODIL; FIBRINOLYTIC AGENT; LUBELUZOLE; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; SEIFOTEL; STREPTOKINASE; TIRILAZAD; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE;

BLEEDING; BRAIN ISCHEMIA; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; DISABILITY; DRUG EFFICACY; EARLY DIAGNOSIS; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; HUMAN; MEDICAL EDUCATION; MEDICAL STAFF; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT; RELATIVE; REVIEW; RISK FACTOR; STROKE; SYMPTOM; TREATMENT OUTCOME;

EID: 0032957214     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.16.1.2     Document Type: Review

References (29)

1. Thorvaldsen P, Asplund K, Kuulasmaa K, et al. Stroke incidence, case fatality and mortality in the WHO MONICA project. World Health Organization monitoring trends and determinants in cardiovascular disease. Stroke 1995;26:361-7.
2. Spitzer K, Becker V, Thie A, et al. The Hamburg stroke data bank: goals, design and preliminary results. J Neurol 1989; 236:139-44.
3. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1996;27:1711-18.
4. Solis O, Robertson G, Taveras J, et al. Cerebral angiography in acute cerebral infarction. Rev Interam Radiol 1979;2:19-25.
5. Allen C. Clinical diagnosis of acute stroke syndrome. Q J Med 1983;42:515-23.
6. Poungvarin N, Viriyavejakul A, Komontri C. Siriraj stroke score and validation study to distinguish supratentorial intracerebral hemorrhage from infarction. BMJ 1991;302: 1565-7.
7. Jafar J, Crowell R. Focal ischemic thresholds. In: Wood J, ed. Cerebral blood flow. New York: McGraw-Hill, 1987: 449-57.
8. Hacke W, Stingele R, Steiner T, et al. Crititcal care of acute ischemic stroke. Intensive Care Med 1995;21:856-62.
9. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981;12:723-5.
10. Caplan L. Reperfusion of ischemic brain: why and why not. In: Hacke W, del Zoppo G, Hirschberg M, eds. Thrombolytic therapy in acute ischemic stroke. Berlin: Springer, 1991: 37-45.
11. Adams HJ, Brott T, Furlan A, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 1996;27:1711-8.
12. The RANTTAS Investigators. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). Stroke 1996;27:1453-8.
13. The European Ad Hoc Consensus Group. European strategies for early intervention in stroke. Cerebrovascular Disease 1996;6:315-24.
14. Alberts M, Perry A, Dawson D, et al. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 1992;23:352-6.
15. Kothari R, Barsan W, Brott T, et al. Frequency and accuracy of prehospital diagnosis of acute stroke. Stroke 1995;26: 937-41.
16. Lott C, Hennes H, Dick W. Prehospital diagnosis in stroke patients - differentiation between cerebral ischemic events and hemorrhage. Intensive Care Med 1996;22 (suppl 1):S96.
17. The American-Canadian Co-Operative Study Group. Presantine aspirin trial in cerebral ischaemia. Part II: endpoint results. Stroke 1985;16:406-15.
18. Bronstein KS, Chadwick LR. Ticlopidine hydrochloride: its current use in cerebrovascular disease. Rehabilitation Nursing 1994;19:17-20.
19. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
20. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995;333:1581-7.
21. Hommel M, Biossel P, Cornu E, et al. for the MAST Study Group. Termination of trial of streptokinase in severe acute ischaemic stroke. Lancet 1994;345:57.
22. Multicenter Acute Stroke Trial Italy (MAST-I). Randomized controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischaemic stroke. Lancet 1995;346:1514.
23. Donnan GA, Davis SM, Chambers BR, et al. Trials of streptokinase in severe acute ischaemic stroke. Lancet 1995;345: 578-9.
24. Walghren NG, MacMahon DG, De Keyser J, et al for the INWEST Study Group. Intravenous Nimodipine West European Stroke Trial of nimodipine in the treatment of acute ischaemic stroke. Cerebrovascular Disease 1994;4: 197-203.
25. Muir KW, Lees KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke 1995;26:503-13.
26. MacDonald JW, Silverstein FS, Johnston MV. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett 1990;109:234-8.
27. Young W, Wojack JC, De Crescito W. 21-aminosteroid reduces ion shift in oedema in the rat middle cerebral occlusion model of regional ischaemia. Stroke 1988;9: 1013-19.
28. RANTTAS Investigators. Randomised trial of tirilizad in acute stroke (RANTTAS) by the RANTTAS investigators, the neuroclinical centre, University of Charlottesville, VA, and the North American RANTTAS participants. Stroke 1996;27:164 (abst).
29. Diener H, Hacke W, Hennerici M. Lubeluzole in acute ischemic stroke: a double-blind placebo controlled phase II trial. Stroke 1996;27:76-81.